Skip to main content

Vestal Point Capital, LP

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1974915 NEW YORK, NY

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$83,000,000
+$16,122,000 QoQ
Shares Held
8,300,000
+18.1% QoQ
Ownership
3.25%
of shares outstanding
% of Portfolio
1.94%
of 13F equity value
Holder Rank
#10
of 316 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Vestal Point Capital, LP holds $635,551,250 across 3 Drug Manufacturers - Specialty & Generic names. BCRX ranks #3 (13.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 BCRX
Biocryst Pharmaceuticals Inc
This page
8,300,000 $83,000,000

All Filings in BCRX

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $83,000,000 8,300,000
2026-03-31 $66,878,000 7,025,000
2025-12-31 $17,550,000 2,250,000